Osaic Holdings
CTMX icon

Osaic Holdings’s CytomX Therapeutics CTMX Stock Holding History

Osaic Holdings’s Portfolio CTMX Stock Details CTMX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$77K Buy
20,531
+4,060
+25% +$15.5K ﹤0.01% 5150
2026
Q1 		$77.4K Sell
16,471
-2,939
-15% -$14.9K ﹤0.01% 4866
2025
Q4 		$82.7K Buy
19,410
+2,700
+16% +$10.3K ﹤0.01% 4863
2025
Q3 		$52.8K Buy
16,710
+500
+3% +$1.13K ﹤0.01% 5277
2025
Q2 		$36.8K Buy
16,210
+860
+6% +$1.39K ﹤0.01% 5261
2025
Q1 		$9.76K Buy
15,350
+14,480
+1,664% +$11.2K ﹤0.01% 5799
2024
Q4 		$896 Sell
870
-30
-3% -$32 ﹤0.01% 6875
2024
Q3 		$1.06K Hold
900
– – ﹤0.01% 6826
2024
Q2 		$1.1K Buy
+900
New +$1.79K ﹤0.01% 6792
2023
Q3 		– Sell
-15,350
Closed -$28.6K – 7420
2023
Q2 		$28.6K Hold
15,350
– – ﹤0.01% 5323
2023
Q1 		$24.6K Sell
15,350
-14
-0.1% -$32 ﹤0.01% 5449
2022
Q4 		$25K Hold
15,364
– – ﹤0.01% 5418
2022
Q3 		$22K Hold
15,364
– – ﹤0.01% 5510
2022
Q2 		$28K Buy
15,364
+15,039
+4,627% +$28.8K ﹤0.01% 5373
2022
Q1 		$1K Buy
325
+311
+2,221% +$1.19K ﹤0.01% 7013
2021
Q4 		$0 Sell
14
-1
-7% -$6 ﹤0.01% 7410
2021
Q3 		$0 Sell
15
-31
-67% -$166 ﹤0.01% 7204
2021
Q2 		$0 Buy
+46
New +$358 ﹤0.01% 7009

Other funds holding CTMX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return

Osaic Holdings's CTMX Position: Q2 2026 in Review

Osaic Holdings increased its CytomX Therapeutics (CTMX) stake by 25% in Q2 2026, buying an estimated $15.5K and bringing the position to 20,531 shares worth $77K. The position accounts for ﹤0.01% of the portfolio, ranked #5150.

Osaic Holdings first reported a position in CTMX in Q2 2021 and has held it in 18 quarters since. The position peaked at $82.7K in Q4 2025. 178 funds tracked by Wall St. Rank hold CTMX as of Q2 2026.

  • Osaic Holdings held 20,531 shares of CytomX Therapeutics worth $77K as of Q2 2026.
  • Osaic Holdings bought 4,060 CytomX Therapeutics shares in Q2 2026, an estimated $15.5K.
  • CytomX Therapeutics made up ﹤0.01% of Osaic Holdings's portfolio in Q2 2026, its #5150 holding.
  • Osaic Holdings first reported a position in CytomX Therapeutics in Q2 2021 and has held it in 18 quarters since.
  • Osaic Holdings's CytomX Therapeutics position peaked at $82.7K in Q4 2025.
  • 178 funds tracked by Wall St. Rank held CytomX Therapeutics as of Q2 2026.

Based on Osaic Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.